WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE
Shanghai
Jin Mao Tower, 38F, Unit 03
88 Century Blvd, Pudong,
Shanghai, 200121
CN

T+86-21-6165-1700

Visiting Our Shanghai Office - An Important Notice Regarding COVID-19:

Our Shanghai office is open and accepting guests. However, we ask that you check with your Wilson Sonsini attorney or other appropriate contact in the office before visiting, as changes in public health conditions may result in additional guidelines or restrictions. We appreciate your understanding and cooperation. 

 ____

With deep ties to Asia's entrepreneurial, financial, investor, and legal communities, Wilson Sonsini has developed a strong and thriving practice in Greater China and neighboring regions. The firm opened an office in Shanghai in 2007, added one in Hong Kong in 2010, and opened another in Beijing in 2012.

The firm's China-based attorneys offer a wide array of legal services and work closely with their colleagues in the U.S. and Europe to leverage the firm's experience and resources on a global scale. Our fully integrated team has approximately 30 bilingual professionals, including six Greater China-based partners who are recognized experts in U.S. and Hong Kong capital markets, private equity, mergers and acquisitions, and corporate governance. Drawing on Wilson Sonsini's comprehensive platform of services and expertise, our firm also represents both U.S.- and Asia-based companies and funds in corporate and venture capital investments, joint ventures, technology transactions, intellectual property matters, antitrust counseling, arbitration, and litigation.

Our clients include leading companies across a broad range of technology, healthcare, and consumer industries, including life sciences and pharmaceuticals, medical devices, communications and networking, digital media and internet, mobile software and hardware, semiconductors, and renewable energy. In addition, our attorneys' deep and nuanced understanding of China's business and political landscapes, as well as its culture, makes the firm an ideal partner for companies, private equity and venture capital funds, and financial institutions in the region.

For more information, please see the firm's Greater China practice page.

Get Directions
Transportation and Directions
Hongqiao International Airport is 25 kilometres away, or 30 minutes by car.

Pudong International Airport is 40 kilometres away, or 50 minutes by car.

Railway station is 12 kilometres away, or 30 minutes by car.

The city's Metro Line II and pedestrian tunnel allow easy access to key points within the city and surrounding areas.
Parking
Visitors to Wilson Sonsini Goodrich & Rosati's Shanghai office can find parking on Levels I, II, or III of the Jin Mao building's basement parking garage.
Related News and Insights
Client Highlights
Wilson Sonsini Advises WuXi AppTec on Sale of China-Based Clinical Research Services Business to Hillhouse
On October 24, 2025, WuXi AppTec Co., Ltd. (WuXi AppTec), a leading global provider of R&D and manufacturing-enabling services in the pharmaceutical, biotechnology, and medical device industries, announced that its wholly owned subsidiary has entered into a sale and purchase agreement to sell its two subsidiaries, WuXi Clinical Development Services (Shanghai) Co., Ltd. (WuXi Clinical) and WuXi MedKey Med-Tech Development (Shanghai) Co., Ltd. (WuXi MedKey), to Hillhouse Investment Management (Hillhouse), one of the world’s leading global private asset managers focusing on sectors such as healthcare, manufacturing, green energy, hard technology, and consumer technology. WuXi Clinical and WuXi MedKey are the operating entities of WuXi AppTec engaged in China-based clinical research services.

Wilson Sonsini Goodrich & Rosati advised WuXi AppTec on the transaction. The Wilson Sonsini team includes:
Learn More
News Articles
CBLJ Ranks Wilson Sonsini Among 2024 Top International Legal Advisers for HKEX Listings
In the annual capital market report published by China Business Law Journal in August 2024, the firm's capital markets practice in Greater China region ranked No. 3 among top international legal advisers in terms of accumulated deal value for HKEX Listings in the 2023 to 2024 cycle. Firm client WuXi XDC’s $471 million Hong Kong IPO is also ranked as the second largest among top ten listings on the Hong Kong Stock Exchange from the 2023 to 2024 cycle.
Learn More
News Articles
Wilson Sonsini Recognized in 2024 China Business Law Awards
On July 24, 2024, Wilson Sonsini was honored as a winning law firm in two categories of China Business Law Journal’s 2024 China Business Law Awards. The firm is named a top international law firm for Capital Markets (Hong Kong & Overseas) and Government and Policy.
Learn More
News Articles
Weiheng Chen Named to China Business Law Journal's 2023-24 A-List (The Visionaries)
On December 12, 2023, Wilson Sonsini partner Weiheng Chen was recognized among the "The Visionaries" for China Business Law Journal's A-List Awards, acknowledging seasoned lawyers who hold key management positions in their firms and prominent public positions.
Learn More
News Articles
Wilson Sonsini Recognized in The Legal 500 Asia Pacific 2024 Guide
On November 15, 2023, The Legal 500 published its Asia Pacific guide, which ranks leading lawyers and law firms in countries across the region. Wilson Sonsini Goodrich & Rosati is recognized as a top law firm in Greater China and ranked for Capital Markets: Equity (Foreign Firms) in Hong Kong and Life Sciences and Healthcare (Foreign Firms) in China.
Learn More
Client Highlights
Firm Advises WuXi XDC on US$470 Million Hong Kong IPO
On November 17, 2023, WuXi XDC Cayman Inc. (WuXi XDC) was successfully listed on the Main Board of the Stock Exchange of Hong Kong, raising approximately HK$3,676 million (US$470 million) from its IPO, or approximately HK$4,070.7 million (US$520.4 million) if the underwriters fully exercise their over-allotment option, making it the third largest IPO and the largest biotech IPO in Hong Kong this year to date. Wilson Sonsini Goodrich & Rosati acted as issuer’s U.S. counsel in the IPO and Hong Kong listing. The firm also acted as the U.S. and Hong Kong counsel of WuXi AppTec Co., Ltd., a controlling shareholder of WuXi XDC (WuXi AppTec), in connection with this transaction. 
Learn More
View All Related News and Insights
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.